Aliases & Classifications for Hyperglycemia

Summaries for Hyperglycemia

MedlinePlus : 41 hyperglycemia means high blood sugar or glucose. glucose comes from the foods you eat. insulin is a hormone that moves glucose into your cells to give them energy. hyperglycemia happens when your body doesn't make enough insulin or can't use it the right way. people with diabetes can get hyperglycemia from not eating the right foods or not taking medicines correctly. other problems that can raise blood sugar include infections, certain medicines, hormone imbalances, or severe illnesses.

MalaCards based summary : Hyperglycemia is related to diabetes mellitus, insulin-dependent, 20 and diabetic cataract, and has symptoms including cachexia, cyanosis and dyspnea. An important gene associated with Hyperglycemia is INS (Insulin), and among its related pathways/superpathways are Developmental Biology and Regulation of lipid metabolism Insulin signaling-generic cascades. The drugs Glipizide and Metformin have been mentioned in the context of this disorder. Affiliated tissues include endothelial, kidney and liver, and related phenotypes are Decreased viability and homeostasis/metabolism

Wikipedia : 71 Hyperglycemia, or high blood sugar (also spelled hyperglycaemia or hyperglycæmia) is a condition in... more...

Related Diseases for Hyperglycemia

Diseases related to Hyperglycemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 271)
id Related Disease Score Top Affiliating Genes
1 diabetes mellitus, insulin-dependent, 20 29.7 ADIPOQ AKR1B1 ALB DPP4 GCG GCK
2 diabetic cataract 29.4 ABCC8 GCK INS INSR SST
3 diabetic encephalopathy 29.3 ADIPOQ IGF1 INS LEP
4 meningitis 29.1 ADIPOQ INS INSR IRS1 LEP
5 hyperinsulinism 11.0
6 glycogen storage disease type 0 11.0
7 diabetes mellitus, transient neonatal, 1 10.9
8 diabetes mellitus, permanent neonatal 10.9
9 mody, type ii 10.9
10 diabetes mellitus, ketosis-prone 10.8
11 mitochondrial complex iii deficiency, nuclear type 6 10.8
12 diabetes mellitus, insulin-dependent 10.8
13 diabetes and deafness, maternally inherited 10.8
14 agenesis of the dorsal pancreas 10.8
15 diabetes mellitus, insulin-dependent, 19 10.6
16 diabetes mellitus, insulin-dependent, 12 10.6
17 diabetes mellitus, insulin-dependent, 22 10.6
18 diabetes, mellitus, insulin-dependent 10 10.6
19 histiocytosis-lymphadenopathy plus syndrome 10.6
20 cataract, juvenile, with microcornea and glucosuria 10.6
21 diabetes mellitus, insulin-dependent, 2 10.6
22 diabetes mellitus, transient neonatal 2 10.6
23 diabetes mellitus, transient neonatal, 3 10.6
24 glycogen storage disease 0, liver 10.6
25 renal glucosuria 10.6
26 diabetes mellitus, 6q24-related transient neonatal 10.6
27 brittle diabetes 10.6
28 intellectual disability-developmental delay-contractures syndrome 10.4 INS INSR
29 microphthalmia, syndromic 8 10.4 GCG INS
30 labyrinthine unilateral reactive loss 10.4 ABCC8 GCK INS
31 diaphanospondylodysostosis 10.4 ABCC8 GCK
32 autoimmune disease 1 10.4 ABCC8 GCG INS
33 nosophobia 10.3 ABCC8 GCK
34 hypercholesterolemia, familial 10.3 ABCC8 INSR
35 peripheral degeneration of cornea 10.3 GCG INS SST
36 diarrhea 3, secretory sodium, congenital, syndromic 10.3 IGF1 INS INSR
37 protein s deficiency 10.3 IGF1 INS SST
38 iida kannari syndrome 10.3 ADIPOQ INS PPARG
39 vaginal adenoma 10.3 IGF1 SST
40 agammaglobulinemia 6 10.3 AKR1B1 ALB INS
41 acquired angioedema 10.3 ADIPOQ PPARG
42 rickets 10.3 GCG IGF1 SST
43 endotheliitis 10.3
44 pelvic muscle wasting 10.3 IGF1 INS INSR
45 brain angioma 10.3 IGF1 IRS1
46 urethra clear cell adenocarcinoma 10.3 IGF1 INS SST
47 non-syndromic intellectual disability 10.3 ABCC8 GCK INS PDX1
48 focal segmental glomerulosclerosis 8 10.3 ABCC8 GCK INS PDX1
49 fissured tongue 10.3 AKR1B1 ALB INS
50 maturity-onset diabetes of the young, type 13 10.3 ABCC8 GCG GCK INS SST

Graphical network of the top 20 diseases related to Hyperglycemia:



Diseases related to Hyperglycemia

Symptoms & Phenotypes for Hyperglycemia

UMLS symptoms related to Hyperglycemia:


cachexia, cyanosis, dyspnea, edema, fever, headache, icterus, seizures, signs and symptoms, signs and symptoms, digestive, syncope, vertigo, hot flushes, symptoms

GenomeRNAi Phenotypes related to Hyperglycemia according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00106-A-0 9.97 UNC13B
2 Decreased viability GR00221-A-1 9.97 PPARG IRS1 UNC13B GCK INSR
3 Decreased viability GR00221-A-2 9.97 INSR PPARG IRS1 UNC13B GCK
4 Decreased viability GR00221-A-3 9.97 INSR PPARG UNC13B GCK
5 Decreased viability GR00221-A-4 9.97 INSR PPARG UNC13B GCK
6 Decreased viability GR00231-A 9.97 GCK
7 Decreased viability GR00342-S-2 9.97 IRS1
8 Decreased viability GR00342-S-3 9.97 IRS1

MGI Mouse Phenotypes related to Hyperglycemia:

44 (show all 12)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.39 GCK IAPP IGF1 INS INSR IRS1
2 growth/size/body region MP:0005378 10.36 ADIPOQ AKR1B1 DPP4 G6PC GCK IAPP
3 endocrine/exocrine gland MP:0005379 10.29 ABCC8 ADIPOQ ALB DPP4 GCK IGF1
4 behavior/neurological MP:0005386 10.24 LEP PPARG SLC2A2 SLC5A2 SST UNC13B
5 mortality/aging MP:0010768 10.2 ADIPOQ AKR1B1 ALB G6PC GCK IGF1
6 immune system MP:0005387 10.14 ADIPOQ IAPP IGF1 INS INSR IRS1
7 adipose tissue MP:0005375 10.11 PPARG SLC5A2 INS INSR IRS1 LEP
8 liver/biliary system MP:0005370 10.11 INSR IRS1 LEP PDX1 PPARG SLC2A2
9 muscle MP:0005369 9.96 ADIPOQ ALB IGF1 INS INSR IRS1
10 renal/urinary system MP:0005367 9.73 ADIPOQ AKR1B1 ALB G6PC GCK IGF1
11 no phenotypic analysis MP:0003012 9.7 ABCC8 INS PDX1 PPARG SLC5A2 SST
12 skeleton MP:0005390 9.36 ADIPOQ AKR1B1 G6PC IAPP IGF1 INS

Drugs & Therapeutics for Hyperglycemia

Drugs for Hyperglycemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 684)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Glipizide Approved Phase 4,Phase 3,Phase 2,Phase 1 29094-61-9 3478
2
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 657-24-9 14219 4091
3
Saxagliptin Approved Phase 4,Phase 3,Phase 2 361442-04-8 11243969
4
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 7440-66-6 32051 23994
5
Aripiprazole Approved, Investigational Phase 4,Phase 3 129722-12-9 60795
6
Insulin Aspart Approved Phase 4,Phase 3,Phase 2,Phase 1 116094-23-6 16132418
7
Insulin Lispro Approved Phase 4,Phase 3,Phase 2,Early Phase 1 133107-64-9
8
Insulin-glulisine Approved Phase 4,Phase 3,Phase 2 207748-29-6
9
Febuxostat Approved Phase 4 144060-53-7 134018
10
Nitric Oxide Approved Phase 4 10102-43-9 145068
11
Nitroglycerin Approved, Investigational Phase 4 55-63-0 4510
12
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 2 56180-94-0 441184
13
Exenatide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 141758-74-9 15991534
14
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
15
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
16 Parecoxib Approved Phase 4 198470-84-7
17
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
18
Insulin Glargine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 160337-95-1
19
Isosorbide Dinitrate Approved Phase 4 87-33-2 6883
20
Amlodipine Approved Phase 4 88150-42-9 2162
21
Atenolol Approved Phase 4 29122-68-7 2249
22
Clonidine Approved Phase 4 4205-90-7 2803
23
Doxazosin Approved Phase 4 74191-85-8 3157
24
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
25
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2 58-93-5 3639
26
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
27
Ramipril Approved Phase 4,Phase 3 87333-19-5 5362129
28
Simvastatin Approved Phase 4,Phase 3,Phase 2 79902-63-9 54454
29
Nateglinide Approved, Investigational Phase 4 105816-04-4 60026
30
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
31
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-23-7 5754 657311
32 Moxonidine Approved Phase 4 75438-57-2 4810
33
Insulin Detemir Approved Phase 4,Phase 3,Phase 2 169148-63-4 5311023
34
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
35
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
36
Rosiglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 122320-73-4 77999
37
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 53-03-2 5865
38
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
39
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
40
Pramlintide Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 151126-32-8
41
Menthol Approved Phase 4,Phase 3 2216-51-5 16666
42
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
43
Fenofibrate Approved Phase 4,Phase 2,Phase 3 49562-28-9 3339
44
Linagliptin Approved Phase 4,Phase 3 668270-12-0 10096344
45
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
46
Voglibose Approved, Investigational Phase 4 83480-29-9 444020
47
Liraglutide Approved Phase 4,Phase 3,Phase 2,Phase 1 204656-20-2
48
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1 64-17-5 702
49
Copper Approved Phase 4 15158-11-9, 7440-50-8 27099
50
Gliclazide Approved Phase 4,Phase 2 21187-98-4 3475

Interventional clinical trials:

(show top 50) (show all 1569)
id Name Status NCT ID Phase
1 Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia Unknown status NCT01267448 Phase 4
2 Intensive Versus Nonintensive Insulin Therapy for Hyperglycemia After Traumatic Brain Injury Unknown status NCT02161055 Phase 4
3 Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia Unknown status NCT00541554 Phase 4
4 Arterial Catheter to Monitor Glycemia Unknown status NCT01176279 Phase 4
5 A Trial Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Mechanical Ventilation in ICU Unknown status NCT02491346 Phase 4
6 CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Unknown status NCT01848990 Phase 4
7 The Effect of Uric Acid Lowering in Type 1 Diabetes Unknown status NCT02344602 Phase 4
8 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4
9 Obtain a Good Blood Glucose Control With the Paradigm Real Time System Unknown status NCT00441129 Phase 4
10 The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients Unknown status NCT01270191 Phase 4
11 Curcumin for Type 2 Diabetic Patients Unknown status NCT01052597 Phase 4
12 Type 2 Diabetes Mellitus and Atherosclerosis Unknown status NCT01250340 Phase 4
13 Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic Surgery Unknown status NCT01930318 Phase 4
14 Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus Unknown status NCT00446810 Phase 4
15 Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial Unknown status NCT01143948 Phase 4
16 Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients With Type 2 Diabetes Mellitus Unknown status NCT02011620 Phase 4
17 Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes. Unknown status NCT00254085 Phase 4
18 Nephropathy In Type 2 Diabetes and Cardio-renal Events Unknown status NCT00535925 Phase 4
19 Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference? Unknown status NCT00259168 Phase 4
20 Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity Unknown status NCT00878592 Phase 4
21 Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics Unknown status NCT01095822 Phase 4
22 Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose Unknown status NCT00145353 Phase 4
23 Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes Unknown status NCT01758471 Phase 4
24 Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity Unknown status NCT01180231 Phase 4
25 Bone Turnover in Type 2 Diabetes Patients Unknown status NCT00732121 Phase 4
26 TReatment by Insulin Continuous Infusion in Type 2 DIAbetes Unknown status NCT01889914 Phase 4
27 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome Unknown status NCT00127985 Phase 4
28 Intensity of Exercise and Glucose Metabolism Unknown status NCT01649219 Phase 4
29 Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance Unknown status NCT01052025 Phase 4
30 Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance Unknown status NCT00733174 Phase 4
31 Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity Unknown status NCT01960205 Phase 4
32 Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy Completed NCT02155374 Phase 4
33 Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia Completed NCT01184014 Phase 4
34 NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens Completed NCT02758522 Phase 4
35 The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients Completed NCT01810952 Phase 4
36 Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery Completed NCT02443402 Phase 4
37 Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia Completed NCT00362778 Phase 4
38 Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery Completed NCT01545700 Phase 4
39 Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes Completed NCT00191282 Phase 4
40 Study of a Model-based Approach to Blood Glucose Control in Very-low-birthweight Neonates Completed NCT01419873 Phase 4
41 A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes Completed NCT01159938 Phase 4
42 Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia Completed NCT01269047 Phase 4
43 Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM) Completed NCT00771693 Phase 4
44 Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation Completed NCT00779701 Phase 4
45 Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings Completed NCT00177398 Phase 4
46 Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (DM) Completed NCT00979628 Phase 4
47 Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery Completed NCT00596687 Phase 4
48 DPP4 Inhibitor in the Hospital Completed NCT01378117 Phase 4
49 Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes Completed NCT00394407 Phase 4
50 Diabetes in the Elderly: Prospective Study Completed NCT01131052 Phase 4

Search NIH Clinical Center for Hyperglycemia

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: hyperglycemia

Genetic Tests for Hyperglycemia

Genetic tests related to Hyperglycemia:

id Genetic test Affiliating Genes
1 Hyperglycemia 29

Anatomical Context for Hyperglycemia

MalaCards organs/tissues related to Hyperglycemia:

39
Endothelial, Kidney, Liver, Brain, Heart, Skeletal Muscle, Monocytes

Publications for Hyperglycemia

Articles related to Hyperglycemia:

(show top 50) (show all 1241)
id Title Authors Year
1
Glycosuria and hyperglycemia in the neonatal period as the first clinical sign of Fanconi-Bickel syndrome. ( 28493372 )
2017
2
Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity. ( 28069641 )
2017
3
Diagnostic protocol for gestational diabetes mellitus (GDM) (IADPSG/ADA, 2011): influence on the occurrence of GDM and mild gestational hyperglycemia (MGH) and on the perinatal outcomes. ( 28053673 )
2017
4
Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice. ( 28061324 )
2017
5
Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia. ( 28042546 )
2017
6
Paternal hyperglycemia in rats exacerbates the development of obesity in offspring. ( 28533422 )
2017
7
Diffuse (18)F-FDG accumulation in the subarachnoid space detected by PET/CT in a patient with subarachnoid hemorrhage and hyperglycemia. ( 28064344 )
2017
8
Urine Albumin Excretion as a Marker of Acute Glycemic Changes in Isolated Postprandial Hyperglycemia. ( 28042215 )
2017
9
MiR-29c/PRKCI Regulates Axonal Growth of Dorsal Root Ganglia Neurons Under Hyperglycemia. ( 28070856 )
2017
10
Hyperglycemia as a Prognosis Predictor of Length of Stay and Functional Outcomes in Patients with Acute Ischemic Stroke. ( 28074658 )
2017
11
Stress hyperglycemia and acute ischemic stroke in-hospital outcome. ( 28081783 )
2017
12
Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention. ( 28056793 )
2017
13
Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies. ( 28058528 )
2017
14
Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARI^, proinflammatory cytokines and oxidative stress. ( 28092845 )
2017
15
Stress induced hyperglycemia after spontaneous subarachnoid hemorrhage and its role in predicting cerebrospinal fluid diversion. ( 28089808 )
2017
16
A unified Hyperglycemia and Diabetic ketoacidosis (DKA) insulin infusion protocol based on an Excel algorithm and implemented via Electronic Medical Record (EMR) in Intensive Care Units. ( 27658894 )
2016
17
PPARGC1I+ gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns. ( 27340502 )
2016
18
Acute hyperglycemia suppresses left ventricular diastolic function and inhibits autophagic flux in mice under prohypertrophic stimulation. ( 27659110 )
2016
19
Hyperglycemia and Advanced Glycation End Products Regulate miR-126 Expression in Endothelial Progenitor Cells. ( 27673690 )
2016
20
Hyperglycemia in Stroke Impairs Polarization of Monocytes/Macrophages to a Protective Noninflammatory Cell Type. ( 27605608 )
2016
21
Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney. ( 26806835 )
2016
22
Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity. ( 28040599 )
2016
23
Mitochondrial Complex III Deficiency with Ketoacidosis and Hyperglycemia Mimicking Neonatal Diabetes. ( 27074787 )
2016
24
Combination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease. ( 27198152 )
2016
25
Association of statin use and stress-induced hyperglycemia in patients with acute ST-elevation myocardial infarction. ( 27158481 )
2016
26
Transgenerational Glucose Intolerance of Tumor Necrosis Factor with Epigenetic Alteration in Rat Perirenal Adipose Tissue Induced by Intrauterine Hyperglycemia. ( 26881249 )
2016
27
Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs. ( 27203422 )
2016
28
Alteration in Expression and Methylation of IGF2/H19 in Placenta and Umbilical Cord Blood Are Associated with Macrosomia Exposed to Intrauterine Hyperglycemia. ( 26840070 )
2016
29
Effective treatment with combination of peripheral 5-hydroxytryptamine synthetic inhibitor and 5-hydroxytryptamine 2 receptor antagonist on glucocorticoid-induced whole-body insulin resistance with hyperglycemia. ( 27177506 )
2016
30
Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study. ( 27226040 )
2016
31
Melatonin receptor 1B gene associated with hyperglycemia in bipolar disorder. ( 26991397 )
2016
32
Maternal and Neonatal Morbidity for Women Who Would Be Added to the Diagnosis of GDM Using IADPSG Criteria: A Secondary Analysis of the Hyperglycemia and Adverse Pregnancy Outcome Study. ( 27634392 )
2016
33
Validation of RT-qPCR reference genes and determination of Robo4 expression levels in human retinal endothelial cells under hypoxia and/or hyperglycemia. ( 27041242 )
2016
34
Comprehensive interpretation of hyperglycemia and hyperosmolality on the clinical outcomes among ischemic stroke patients. ( 27614372 )
2016
35
Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis? ( 27657056 )
2016
36
Inpatient hyperglycemia management: A practical review for primary medical and surgical teams. ( 27176681 )
2016
37
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways. ( 27278736 )
2016
38
Widespread blunting of hypothalamic and amygdala-septal activity and behavior in rats with long-term hyperglycemia. ( 27173433 )
2016
39
Acute Hyperglycemia Does Not Affect Brain Swelling or Infarction Volume After Middle Cerebral Artery Occlusion in Rats. ( 26463957 )
2016
40
Metabonomics study of the therapeutic mechanism of fenugreek galactomannan on diabetic hyperglycemia in rats, by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. ( 28063302 )
2016
41
Lipid metabolism in patients with chronic hyperglycemia after an episode of acute pancreatitis. ( 28065464 )
2016
42
Does hyperglycemia in hypernatremic preterm infants increase the risk of intraventricular hemorrhage? ( 27195979 )
2016
43
Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia. ( 26873505 )
2016
44
Short-term change of carotid intima-media thickness after treatment of hyperglycemia in patients with diabetes: a cross-sectional study. ( 27215550 )
2016
45
Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor. ( 27626493 )
2016
46
Chromium supplementation improved post-stroke brain infarction and hyperglycemia. ( 26477944 )
2016
47
Hyperglycemia decreases expression of 14-3-3 proteins in an animal model of stroke. ( 27177727 )
2016
48
Acute severe illness in diabetes patients: is tolerating hyperglycemia beneficial? ( 28066571 )
2016
49
Mild hyperglycemia triggered islet function recovery in STZ-induced insulin-deficient diabetic rats. ( 27184687 )
2016
50
Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx. ( 26908090 )
2016

Variations for Hyperglycemia

Copy number variations for Hyperglycemia from CNVD:

7
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 44162 10 52900000 70600000 Copy number TFAM Hyperglycemia

Expression for Hyperglycemia

Search GEO for disease gene expression data for Hyperglycemia.

Pathways for Hyperglycemia

Pathways related to Hyperglycemia according to GeneCards Suite gene sharing:

(show all 39)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.48 ADIPOQ GCK IAPP INS IRS1 LEP
2
Show member pathways
12.88 G6PC GCK IGF1 INS INSR IRS1
3
Show member pathways
12.83 AKR1B1 G6PC GCK SLC2A2 SLC5A2
4
Show member pathways
12.75 ADIPOQ INS INSR IRS1 LEP
5 12.56 G6PC IGF1 INS INSR IRS1
6
Show member pathways
12.47 GCK INS IRS1 LEP SLC2A2
7 12.39 ADIPOQ GCG INS INSR IRS1 PDX1
8
Show member pathways
12.34 ABCC8 ADIPOQ GCG INS SLC2A2
9
Show member pathways
12.31 ABCC8 ALB GCG GCK INS PDX1
10
Show member pathways